Investor Relations

Corporate Profile

PharmAthene was formed in 2001 to meet the critical needs of this Nation and its Allies by developing biological and chemical defense products. The Company is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used... More >>

NYSE Amex - PIP (Common Stock)
$1.74 + 0.13
Stock chart for: PIP.A.  Currently trading at $1.74 with a 52 week high of $2.10 and a 52 week low of $1.20.
10/08/15 3:59 p.m. ET
Data Provided by Thomson Reuters

Recent News

PharmAthene Announces Conclusion of Oral Arguments In Its Litigation Against SIGA

Read More

PharmAthene Reports Second Quarter 2015 Financial and Operational Results

Read More

Immunovaccine and PharmAthene Sign Exclusive Worldwide License Agreement to Develop and Commercialize an Anthrax Vaccine Formulated in DepoVaxTM

Read More

Upcoming Event

There are currently no events scheduled.

Annual Report

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
*PharmAthene, Inc. makes no representations or warranties with respect to the accuracy or completeness of the information provided herein and assumes no responsibility for correcting, updating, or supplementing any such information.